Posts by Christine Bain, Ph.D.
Christine brings more than 25 years of experience in immunology and coordination of immune monitoring studies in the context of clinical trials in oncology and infectious diseases. She is now in charge of scientific affairs, from the development of internal R&D programs to the implementation of external collaborative projects with our partners.

Ligand binding assays (LBAs) have been our core activity for decades. LBAs are commonly used to measure interactions between two proteins, a ligand and its receptor, a monoclonal antibody (mAb) and its target, or biologics and Anti-Drug Antibodies (ADA). Throughout the development of New…

A biomarker is a defined characteristic that is measured as an indicator of normal biological processes, pathogenic processes, or biological responses to an exposure or intervention, including therapeutic interventions(1). With the development of innovative and personalized therapies, biomarker tracking is increasingly important to support the clinical development…